Search

everythinglearnresearchcommunity

for

Search:↓

DHT affects testicular development and regulates spermatogenesis in some fish.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Artemisia sieversiana extract may help prevent hair loss and promote hair growth.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Testosterone may influence COVID-19 severity and outcomes.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

A man with testotoxicosis was fertile despite low FSH levels, suggesting high testosterone may allow sperm production without FSH.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

SHBG binding properties are unchanged in male liver cirrhosis patients.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

VEGF and its receptor might cause hair loss.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.